Record results mark 21st consecutive quarter of revenue growth
Q3 2008 Highlights:
- Product revenues increased 29% to a record $66.0 million
- Direct (Non-OEM) Business revenues increased by 48%
- Shipped 30,700 new pulse oximeters and Pulse CO-Oximeters
IRVINE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, today announced its financial results for the 2008 third fiscal quarter.
For the third quarter of 2008, Masimo reported product revenues of $66.0 million representing a 29% increase over $51.1 million for the third quarter of 2007. Including royalty revenues, Masimo reported total 2008 third quarter revenues of $78.1 million compared to $64.4 million for the third quarter of 2007. Net income for the 2008 third quarter was $13.1 million or $0.22 per common share compared to $6.9 million or $0.16 per common share for the third quarter of 2007.
During the third quarter of 2008, Masimo also reported that it shipped 30,700 Masimo SET and Masimo Rainbow SET oximetry units, excluding handheld units, compared to 30,800 units in the same prior year quarter. For the first nine months of 2008, Masimo has shipped 88,400 new units representing an annualized increase of 25% over the estimated 470,000 Masimo units in the market as of December 2007 and has now increased its total worldwide net installed base to 540,000 units.
In the third quarter of 2008, revenues from Masimo Rainbow SET products
increased by 85% from the same prior year quarter to $3.0 million. For the
first nine months of 2008, revenues from Masimo Rainbow SET prod
|SOURCE Masimo Corporation|
Copyright©2008 PR Newswire.
All rights reserved